By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3388 Mike Collins Drive

Eagan  Minnesota  55121  U.S.A.
Phone: 651-675-0300 Fax: 651-675-0400



Company News
Biothera Expands Relationship With Merck & Co. (MRK), Enters Collaboration For Combination Cancer Immunotherapy Trials In Multiple Indications 8/24/2016 10:50:14 AM
Biothera To Present At The Canaccord Genuity Growth Conference 8/3/2016 11:10:19 AM
Biothera Presents New Cancer Immunotherapy Research At The 2016 AACR Annual Meeting 4/19/2016 1:07:15 PM
Biothera Announces Presentations at Upcoming AACR Annual Meeting 3/17/2016 11:12:51 AM
Biothera Announces Imprime PGG Positive Safety Findings And Pharmacokinetic Data From Two Phase 1 Studies, As Published In Investigational New Drugs: The Journal Of New Anticancer Agents 2/25/2016 10:30:59 AM
Biothera’s Imprime PGG And Anti-Angiogenic Antibodies Work In Concert To Re-Orient The Immune Microenvironment To Support Cancer Killing, Study Finds 11/6/2015 8:09:11 AM
Biothera's Imprime PGG And Monoclonal Antibody Therapy Alleviates Immune Suppression In Tumor Microenvironment And Increases Cancer Cell Killing 11/6/2015 8:08:12 AM
Biothera To Present Three Abstracts At AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/2/2015 10:00:27 AM
Biothera Appoints Dr. Jose Iglesias As Chief Medical Officer 10/15/2015 10:57:49 AM
Biothera’s Cancer Immunotherapy Drug Imprime PGG Elicits Increased Natural Killer Cell Activation And Cancer Cell Killing 9/18/2015 9:13:40 AM